Françoise Farace

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

British journal of cancer

NPJ precision oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer 130 (4) (2024)
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Mihaela Aldea, Aurélie Honore, Yann Lecluse, Karen Howarth, Luc Friboulet, Benjamin Besse, David Planchard, Françoise Farace
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British journal of cancer (2024)
Marianne Oulhen, Patrycja Pawlikowska, Tala Tayoun, Marianna Garonzi, Genny Buson, Claudio Forcato, Nicolo Manaresi, Agathe Aberlenc, Laura Mezquita, Yann Lecluse, Pernelle Lavaud, Charles Naltet, David Planchard, Benjamin Besse, Françoise Farace
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. NPJ precision oncology 5 (1) (2021)
Vincent Faugeroux, Emma Pailler, Marianne Oulhen, Olivier Deas, Laura Brulle-Soumare, Céline Hervieu, Virginie Marty, Kamelia Alexandrova, Kiki C Andree, Nikolas H Stoecklein, Dominique Tramalloni, Stefano Cairo, Maud NgoCamus, Claudio Nicotra, Leon W M M Terstappen, Nicolo Manaresi, Valérie Lapierre, Karim Fizazi, Jean Yves Scoazec, Yohann Loriot, Jean-Gabriel Judde, Françoise Farace
Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model. Nature communications 11 (1) (2020)

Françoise Farace.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Françoise Farace